INFLUENCE OF ONCE-MONTHLY RIFAMPICIN AND DAILY CLOFAZIMINE ON THE PHARMACOKINETICS OF DAPSONE IN LEPROSY PATIENTS IN NIGERIA

被引：16

作者：

PIETERS, FAJM ^{[1
]}

WOONINK, F ^{[1
]}

ZUIDEMA, J ^{[1
]}

机构：

[1] MANGU LEPROSY & REHABIL CTR,MANGU,NIGERIA

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1988年 / 34卷 / 01期

关键词：

D O I：

10.1007/BF01061421

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：73 / 76

页数：4

共 50 条

[1] THE INFLUENCE OF ONCE-MONTHLY RIFAMPICIN AND OF DAILY CLOFAZIMINE ON THE PHARMACOKINETICS OF DAPSONE IN LEPROSY PATIENTS
ZUIDEMA, J
PIETERS, F
JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 27 (09): : 708 - 708
[2] ONCE-MONTHLY RIFAMPICIN PLUS DAILY DAPSONE IN INITIAL TREATMENT OF LEPROMATOUS LEPROSY
YAWALKAR, SJ
MCDOUGALL, AC
LANGUILLON, J
GHOSH, S
HAJRA, SK
OPROMOLLA, DVA
TONELLO, CJS
LANCET, 1982, 1 (8283): : 1199 - 1202
[3] THE EFFECT OF CLOFAZIMINE ON THE PHARMACOKINETICS OF RIFAMPICIN AND DAPSONE IN LEPROSY
VENKATESAN, K
MATHUR, A
GIRDHAR, BK
BHARADWAJ, VP
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 18 (06) : 715 - 718
[4] A CONTROLLED TRIAL TO COMPARE THE THERAPEUTIC EFFECTS OF DAPSONE IN COMBINATION WITH DAILY OR ONCE-MONTHLY RIFAMPIN IN PATIENTS WITH LEPROMATOUS LEPROSY
OPROMOLLA, DVA
TONELLO, CJS
MCDOUGALL, AC
YAWALKAR, SJ
INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES, 1981, 49 (04) : 393 - 397
[5] A POSSIBLE FLU SYNDROME ON ONCE-MONTHLY RIFAMPICIN
NAAFS, B
MATEMERA, BO
LEPROSY REVIEW, 1986, 57 (03) : 271 - 272
[6] THERAPEUTIC EFFECTS OF ADDING RIMACTANE (RIFAMPICIN) 450 MILLIGRAMS DAILY OR 1200 MILLIGRAMS ONCE MONTHLY IN A SINGLE DOSE TO DAPSONE 50 MILLIGRAMS DAILY IN PATIENTS WITH LEPROMATOUS LEPROSY
LANGUILLON, J
YAWALKAR, SJ
MCDOUGALL, AC
INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES, 1979, 47 (01) : 37 - 43
[7] RIFAMPIN 1200 MG ONCE MONTHLY TOGETHER WITH DAILY LAMPRENE AND DAPSONE IN TREATMENT OF REFRACTORY PATIENTS WITH LEPROMATOUS LEPROSY
PAUL, BS
ROSE, ET
INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES, 1981, 49 (03) : 342 - 343
[8] LEPROMATOUS LEPROSY BEFORE AND AFTER TRIPLE-CHEMOTHERAPY WITH RIFAMPICIN, CLOFAZIMINE AND DAPSONE
NURNBERGER, F
EDORH, AE
SCHOBER, E
SCHALLER, KF
JOURNAL OF CUTANEOUS PATHOLOGY, 1980, 7 (03) : 181 - 181
[9] THERAPEUTIC EFFECTS OF ADDING RIMACTANE (RIFAMPICIN) 450-MG DAILY OR 1200-MG ONCE MONTHLY IN A SINGLE DOSE TO DAPSONE 50-MG DAILY IN PATIENTS WITH LEPROMATOUS LEPROSY
LANGUILLON, J
YAWALKAR, SJ
MCDOUGALL, AC
INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES, 1979, 47 (02) : 436 - 436
[10] Aplastic anaemia associated with multidrug therapy (dapsone, rifampicin and clofazimine) in a patient with lepromatous leprosy
Goulart, IMB
Reis, ACS
De Rezende, TMN
Borges, AS
Ferreira, MS
Nishioka, SA
LEPROSY REVIEW, 2005, 76 (02) : 167 - 169

← 1 2 3 4 5 →